Cardiac resynchronization therapy in women: US Food and Drug Administration meta-analysis of patient-level data.
暂无分享,去创建一个
David G. Strauss | William E. Sanders | I. Piña | D. Strauss | R. Zusterzeel | Ileana L. Piña | W. Sanders | Robbert Zusterzeel | Kimberly A. Selzman | K. O’Callaghan | D. Caños | Jamie L. Carpenter | Daniel A. Caños | KathrynM. O’Callaghan | D. Canos
[1] Ping Zhang,et al. True complete left bundle branch block morphology strongly predicts good response to cardiac resynchronization therapy. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[2] Katherine C. Wu,et al. Right, but not left, bundle branch block is associated with large anteroseptal scar. , 2013, Journal of the American College of Cardiology.
[3] Laura G. Qualls,et al. QRS duration, bundle-branch block morphology, and outcomes among older patients with heart failure receiving cardiac resynchronization therapy. , 2013, JAMA.
[4] Frank Rockhold,et al. Access to patient-level data from GlaxoSmithKline clinical trials. , 2013, The New England journal of medicine.
[5] William T. Abraham,et al. An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure , 2013, European heart journal.
[6] Harlan M. Krumholz,et al. A Historic Moment for Open Science: The Yale University Open Data Access Project and Medtronic , 2013, Annals of Internal Medicine.
[7] R. Steinbrook. The European Medicines Agency and the brave new world of access to clinical trial data. , 2013, JAMA internal medicine.
[8] I. Piña,et al. Left bundle branch block predicts better survival in women than men receiving cardiac resynchronization therapy: long-term follow-up of ∼ 145,000 patients. , 2012, JACC. Heart failure.
[9] M. Link,et al. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2012, Journal of the American College of Cardiology.
[10] M. Link,et al. 2012 ACCF/AHA/HRS Focused Update of the 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2012, Heart rhythm.
[11] Jiang Liu,et al. Interferon responsiveness does not change in treatment-experienced hepatitis C subjects: implications for drug development and clinical decisions. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] J. Daubert,et al. Effect of QRS Duration and Morphology on Cardiac Resynchronization Therapy Outcomes in Mild Heart Failure: Results From the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) Study , 2012, Circulation.
[13] G. Mascioli,et al. Electrocardiographic Criteria of True Left Bundle Branch Block: A Simple Sign to Predict a Better Clinical and Instrumental Response to CRT , 2012, Pacing and clinical electrophysiology : PACE.
[14] Guoxing Soon,et al. Meta-analysis of gender differences in efficacy outcomes for HIV-positive subjects in randomized controlled clinical trials of antiretroviral therapy (2000-2008). , 2012, AIDS patient care and STDs.
[15] M. Gold,et al. Potential mechanisms underlying the effect of gender on response to cardiac resynchronization therapy: insights from the SMART-AV multicenter trial. , 2012, Heart rhythm.
[16] R. Redberg,et al. Evaluating sex differences in medical device clinical trials: time for action. , 2012, JAMA.
[17] D. Rowland,et al. Effect of QRS morphology on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials. , 2012, American heart journal.
[18] H. Wiste,et al. Cardiac Resynchronization Therapy: Do Women Benefit More Than Men? , 2012, Journal of cardiovascular electrophysiology.
[19] S. Solomon,et al. Predictors of Response to Cardiac Resynchronization Therapy in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) , 2011, Circulation.
[20] D. Rowland,et al. Impact of QRS duration on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials. , 2011, Archives of internal medicine.
[21] Jeroen J. Bax,et al. Comparison of long-term survival of men versus women with heart failure treated with cardiac resynchronization therapy. , 2011, The American journal of cardiology.
[22] David G Strauss,et al. Defining left bundle branch block in the era of cardiac resynchronization therapy. , 2011, The American journal of cardiology.
[23] Paul J. Wang,et al. Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT-CRT) , 2011, Circulation.
[24] L. Bero,et al. Gender Bias in Studies for Food and Drug Administration Premarket Approval of Cardiovascular Devices , 2011, Circulation. Cardiovascular quality and outcomes.
[25] S. Solomon,et al. Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) trial. , 2011, Journal of the American College of Cardiology.
[26] John L Sapp,et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure. , 2010, The New England journal of medicine.
[27] Kenneth C Bilchick,et al. Bundle-Branch Block Morphology and Other Predictors of Outcome After Cardiac Resynchronization Therapy in Medicare Patients , 2010, Circulation.
[28] O. Pahlm,et al. Appendix 1: Adult Normal Limits , 2010 .
[29] Wojciech Zareba,et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. , 2009, The New England journal of medicine.
[30] A. Waldo. Randomized Trial of Cardiac Resynchronization in Mildly Symptomatic Heart Failure Patients and in Asymptomatic Patients With Left Ventricular Dysfunction and Previous Heart Failure Symptoms , 2009 .
[31] J. Daubert,et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. , 2005, The New England journal of medicine.
[32] D. DeMets,et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. , 2004, The New England journal of medicine.